Personalized meal planning for chronic conditions using labs and meds

Executive Summary

Many people with diabetes, chronic kidney disease, and hypertension struggle to translate clinical recommendations into daily meals, and this gap increases risk, drives medication adjustments, and raises healthcare costs; a reachable subset of 5,000,000 users willing to pay could represent a $1.2 billion annual market at $20 per month. Patients, caregivers, and clinicians all report that generic diet apps fail to account for real-time lab values, medication interactions, or comorbid restrictions, creating adherence barriers and potential safety issues. You could build a subscription service that ingests labs, CGM or home device data, and active medication lists to generate clinician-vetted, medication-aware meal plans, recipes, and shopping lists that update automatically as biomarkers change. The product would combine evidence-based nutrition rules, a rules engine for drug-diet interactions, optional dietitian telehealth escalation, and integrations with EHR and payer systems for referrals and reimbursement, with the $20/month price point validated by the market sizing assumption. This market is attractive now because disease prevalence is rising, payers and health systems are piloting food-as-medicine programs, and APIs and consumer devices make objective personalization feasible. To stand out you must prioritize clinical validation, safety-first medication logic, measurable outcomes tied to cost savings, and partnerships with health systems, while acknowledging clear challenges - namely data interoperability, regulatory and liability risk, and customer acquisition costs in a medium-competition field.